Literature DB >> 31398506

Electrochemical behaviour of anticancer drug lomustine and in situ evaluation of its interaction with DNA.

Paulina Andréa V de Carvalho1, Ilanna Campelo Lopes2, Elizaura Hyeda C Silva2, Evellin Enny S Bruzaca2, Hugo José Alves3, Mayara Ingrid S Lima3, Auro Atsushi Tanaka4.   

Abstract

Electrochemical techniques were used to investigate the behavior of lomustine (CCNU) and its degradation in aqueous solution at a glassy carbon electrode (GCE). The in situ interaction of CCNU and chemically degraded CCNU (cdCCNU) with dsDNA was then investigated in dsDNA incubated solutions, using dsDNA electrochemical biosensors and comet assays. CCNU undergoes electrochemical reduction in two irreversible, diffusion-controlled, and pH-dependent redox processes, each with transfer of two electrons and one proton. At pH ≥ 10.1, the peak potential for the two processes was essentially pH-independent and involved only one electron. A mechanism was proposed for the reduction of CCNU in a neutral medium. In addition, it was found that CCNU underwent spontaneous degradation during incubation in aqueous solution, without the formation of electroactive degradation products. The degradation process was faster in basic media. Moreover, this pro-drug interacted with the DNA. Its metabolite(s) initially caused condensation of the double helix chains, followed by the unwinding of these chains. In addition, free guanine (Gua) was released from the dsDNA and oxidative damage to the DNA by the CCNU metabolite(s) was evidenced from the detection of 8-oxoGua and 2,8-oxoAde. These results were confirmed by the poly(dA)- and poly(dG)-polyhomonucleotide biosensors, which revealed the oxidative damage caused to both bases (guanine and adenine) of the dsDNA by the CCNU metabolite(s). The comet assay indicated breaks in the single strand DNA, complementing the results of the studies using differential pulse voltammetry. Conformational changes of dsDNA caused by CCNU and cdCCNU were confirmed using comet assays.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA; biosensor; lomustine; nitrosurea

Mesh:

Substances:

Year:  2019        PMID: 31398506     DOI: 10.1016/j.jpba.2019.112786

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

Review 1.  DNA Electrochemical Biosensors for In Situ Probing of Pharmaceutical Drug Oxidative DNA Damage.

Authors:  Ana-Maria Chiorcea-Paquim; Ana Maria Oliveira-Brett
Journal:  Sensors (Basel)       Date:  2021-02-05       Impact factor: 3.576

Review 2.  Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties.

Authors:  Giuseppina Ioele; Martina Chieffallo; Maria Antonietta Occhiuzzi; Michele De Luca; Antonio Garofalo; Gaetano Ragno; Fedora Grande
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

Review 3.  What Can Electrochemical Methods Offer in Determining DNA-Drug Interactions?

Authors:  Sandra Ramotowska; Aleksandra Ciesielska; Mariusz Makowski
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

4.  Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin in vivo and in vitro.

Authors:  Tingting Lang; Nuannuan Li; Jing Zhang; Yi Li; Rong Rong; Yuanlei Fu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.